Mental Health

Reunion Neuroscience Appoints Mark Pollack, M.D., as Chief Medical Officer

MORRISTOWN, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment…

2 months ago

Employee Benefit News names Elevate’s Brian Strom as Outstanding Tech Innovator

Elevate CTO and co-founder honored with Excellence in Benefits award DENVER, Sept. 9, 2024 /PRNewswire/ -- Elevate announced that its…

2 months ago

MNA Nurses at Marlborough Hospital to Hold Informational Picket on Sept. 10 in support of Their Patients and the Community

Workplace violence, high RN turnover, and dangerous nurse staffing conditions plague hospital MARLBOROUGH, Mass., Sept. 9, 2024 /PRNewswire/ -- The…

2 months ago

Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health

Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),…

2 months ago

New England Biolabs® Announces 2024 Passion in Science Awards® Recipients

Twelve scientists to be recognized for their inspiring achievements in science mentorship, environmental stewardship, humanitarian efforts and the arts. IPSWICH,…

3 months ago

Revitalist Lifestyle and Wellness Ltd. Partners with Wake Network to Launch Lion’s Brain Supplements for Enhanced Mental Clarity and Wellbeing

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),…

3 months ago

Magellan Health Launches Mental Wellbeing App for Young People

Powered by BeMe Health, the mobile app provides resources and support to address real-time mental health needs for teenagers and…

3 months ago

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs

Company's Canalevia®-CA1 prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first…

3 months ago

Compassion Center Urges DEA to Reschedule Cannabis to Schedule III During December 2, 2024, Hearing

Compassion Center urges the DEA to reschedule cannabis to Schedule III of the Controlled Substances Act during the December 2,…

3 months ago